Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 65, Issue 8
Volume 65, Issue 8
15 October 2017
ISSN 1058-4838
EISSN 1537-6591

Volume 65, Issue 8, 15 October 2017

NEWS

Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages i–ii, https://doi.org/10.1093/cid/cix738

IN THE LITERATURE

Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages iii–iv, https://doi.org/10.1093/cid/cix722

ARTICLES AND COMMENTARIES

Pierluigi Viale and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1253–1259, https://doi.org/10.1093/cid/cix548

Mortality in patients with severe sepsis and septic shock (SS/SS) attending the emergency department (ED) is considerably high. An early bedside intervention by a dedicated infectious diseases team improves both management and outcome of patients with SS/SS attending the ED.

Ana Carolina Bernardes Terzian and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1260–1265, https://doi.org/10.1093/cid/cix558

The mechanism of Zika virus (ZIKV)–induced microcephaly is not well understood. Studies suggest antibody-dependent enhancement (ADE) induced by dengue antibodies. ADE wasn’t observed in vivo in patients who had a dengue virus infection followed by a secondary ZIKV infection.

Elena Losina and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1266–1271, https://doi.org/10.1093/cid/cix547

Cardiovascular disease (CVD) is an increasing cause of morbidity among persons living with human immunodeficiency virus (PLWH). CVD prevention strategies could offer important health benefits for PLWH and should be evaluated.

Yiannis Koullias and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1274–1281, https://doi.org/10.1093/cid/cix542

Testing for integrase inhibitor resistance at the time of HIV diagnosis, in addition to current standard-of-care genotypes, should not be recommended in treatment guidelines; our model-based analysis suggests that testing will likely result in worse clinical outcomes and increased costs.

Kevin Antoine Brown and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1282–1288, https://doi.org/10.1093/cid/cix532

We sought to explain the drivers of large differences in Clostridium difficile infection rates across acute and long-term care facilities. We found that facility antibiotic use and importation of C. difficile cases were strongly associated with infection rates.

Carmen Arriola and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1289–1297, https://doi.org/10.1093/cid/cix468

Our analysis show that influenza vaccination attenuated adverse outcomes among adults that were hospitalized with laboratory-confirmed influenza during 2013−14 influenza season, a season in which vaccine viruses were antigenically similar to those circulating.

Ursula K Rohlwink and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1298–1307, https://doi.org/10.1093/cid/cix540

Neurospecific biomarkers were elevated in pediatric tuberculous meningitis and showed an increasing temporal profile in patients who died, whereas markers of inflammation decreased in all patients regardless of outcome. Secondary injury mechanisms initiated by inflammation likely cause ongoing brain damage.

Jessica L Prodger and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1308–1315, https://doi.org/10.1093/cid/cix478

A large cohort of Ugandans had a 3-fold lower frequency of cells latently infected with human immunodeficiency virus type 1, compared with reports in Americans, a difference not accounted for by pre–antiretroviral therapy viral set point or other demographics.

The AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1316–1326, https://doi.org/10.1093/cid/cix480

Men and women in South Africa and men who have sex with men remain at increased risk of Kaposi sarcoma compared with other human immunodeficiency virus–positive persons receiving antiretroviral therapy, probably owing to high human herpesvirus 8 coinfection rates.

Nadim G El Chakhtoura and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1327–1334, https://doi.org/10.1093/cid/cix559

We assembled a large cohort of patients from the Veterans Health Administration with bloodstream infections caused by Burkholderia cepacia complex from 1999 through 2015. We observed high mortality, high resistance rates to ceftazidime, and limited use of trimethoprim-sulfamethoxazole and ceftazidime.

Stein Schalkwijk and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1335–1341, https://doi.org/10.1093/cid/cix534

During late pregnancy, rilpivirine exposure was lowered by 45%, potentially leading to subtherapy. Despite lower exposure, no perinatal transmission or virologic breakthrough was observed. Once-daily rilpivirine 25 mg may be an alternative treatment option for virologically suppressed pregnant women.

Caroline A O’Neil and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1342–1348, https://doi.org/10.1093/cid/cix535

Measurement of the aerosols generated during 7 healthcare procedures showed an increase in particle concentrations over baseline only during nebulized medication administration (NMA) and bronchoscopy with NMA. Recovered bacteria were common environmental organisms.

Tadahiro Goto and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1349–1355, https://doi.org/10.1093/cid/cix541

In this self-controlled case-series analysis using bariatric surgery as an instrument of weight reduction, the risk of skin and soft-tissue infection and respiratory infection decreased significantly after bariatric surgery, whereas the risk of intra-abdominal infection and urinary tract infection increased.

Clement G Adu-Gyamfi and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1356–1363, https://doi.org/10.1093/cid/cix550

Existing tuberculosis diagnostics fail to distinguish active tuberculosis from latent or cured disease. Indoleamine 2, 3-dioxygenase, an interferon γ–inducible enzyme, is a blood-based tuberculosis biomarker that performed with high accuracy in patients with human immunodeficiency virus infection.

Maha R Farhat and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1364–1370, https://doi.org/10.1093/cid/cix556

A retrospective study of tuberculosis (TB) treatment outcome in 172 multidrug-resistant/extensively drug-resistant TB patients from Peru shows that gyrA/B resistance mutation detection is no different that culture-based fluoroquinolone drug susceptibility testing in predicting death or treatment failure.

Maria Eva Andersson and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1371–1377, https://doi.org/10.1093/cid/cix500

Polymerase chain reaction analysis of rectal swabs from 127 children in rural Zanzibar, taken at time of acute diarrhea and 14 days later, indicates that children in poor settings are heavily exposed to, but rapidly clear, causative and coinfecting enteric pathogens.

VIEWPOINTS

Christine Årdal and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1378–1382, https://doi.org/10.1093/cid/cix526

Pharmaceutical companies’ declining investment in antimicrobials and the rise of resistance has led to calls for alternative business models for antibacterial drugs. This article describes the pros and cons of the various pull incentives/alternative market models that have been proposed.

Lindsay McKenna and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1383–1387, https://doi.org/10.1093/cid/cix533

We provide a community viewpoint on the risks and benefits of including pregnant women in research to address different forms of tuberculosis that includes recent examples of progress in this area and recommendations for researchers, regulatory authorities, ethics committees, and policymakers.

REVIEW ARTICLE

Eleftheria Vasileiou and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1388–1395, https://doi.org/10.1093/cid/cix524

Findings of randomized controlled trials and robust quasi-experimental and epidemiological studies suggest likely benefits of influenza vaccination for persons with asthma, with reductions in influenza infection, respiratory illness, asthma attacks, and emergency department visits and hospitalizations for influenza-related asthma complications.

BRIEF REPORTS

Benjamin D Sirbu and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1396–1399, https://doi.org/10.1093/cid/cix529
Kayla G Barnes and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1400–1403, https://doi.org/10.1093/cid/cix518
Henning Gruell and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1404–1406, https://doi.org/10.1093/cid/cix520
Elisa Vanino and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1407–1409, https://doi.org/10.1093/cid/cix503
Susan T Cookson and Susan A Maloney
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1410–1411, https://doi.org/10.1093/cid/cix508

INVITED ARTICLE

HEALTHCARE EPIDEMIOLOGY

Hajime Kanamori and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1412–1419, https://doi.org/10.1093/cid/cix462

Patient care items can be contaminated with healthcare-associated pathogens and serve as a fomite in healthcare facilities. We review the role of patient care items as a fomite and prevention of fomite-related healthcare-associated outbreaks.

PHOTO QUIZ

Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Page 1420, https://doi.org/10.1093/cid/cix408

ANSWER TO THE PHOTO QUIZ

Seok Ho Hong and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1421–1422, https://doi.org/10.1093/cid/cix410

CORRESPONDENCE

Claudia C Dobler
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Page 1423, https://doi.org/10.1093/cid/cix516
Christina Greenaway and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1423–1424, https://doi.org/10.1093/cid/cix521
Adriana Jimenez and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1424–1425, https://doi.org/10.1093/cid/cix537
Aurélien Dinh and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1425–1426, https://doi.org/10.1093/cid/cix538
Rishi Chanderraj and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1426–1427, https://doi.org/10.1093/cid/cix551
Nicholas S Britt and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1427–1428, https://doi.org/10.1093/cid/cix553
Ashley Marx and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1428–1429, https://doi.org/10.1093/cid/cix552
Allan R Tunkel and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1429–1430, https://doi.org/10.1093/cid/cix554

ERRATA

Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1431–1433, https://doi.org/10.1093/cid/cix563
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1433–1434, https://doi.org/10.1093/cid/cix576
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Page 1435, https://doi.org/10.1093/cid/cix587

COVER

Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Page NP, https://doi.org/10.1093/cid/cix764
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close